EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluating the risk of obstructive sleep apnea at a urology clinic

Jainik Shah, Connor Roque, Sahand Malek Marzban, Maximilian G. Fidel, Yool Ko, Harliv Dhillon, Avinash Sarcar, Rachele Molyneaux, Premal Patel

Canadian Urological Association Journal · 2026-10-19 · 21 (2)

DOI: 10.5489/cuaj.9695 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Obstructive sleep apnea (OSA) is a common condition marked by recurrent upper airway obstruction, affecting 2–4% of middle-aged adults. Its prevalence increases with age, body mass index (BMI), and central adiposity. Beyond its respiratory consequences, OSA is linked to several urologic conditions, including benign prostatic hyperplasia, erectile dysfunction, and low testosterone. This study evaluated the prevalence of OSA screen-positivity among men attending a specialized urology clinic and explored their access to and experiences with primary care providers (PCP). Methods: A cross-sectional survey was administered to consecutive male patients aged 18 years or older presenting between September 2024 and May 2025. Demographic and clinical data were collected, and OSA risk was assessed using the STOP-Bang questionnaire, stratifying participants into risk categories. Statistical comparisons included Chi-squared/Fisher’s exact and Kruskal-Wallis tests. Results: Among 140 respondents (median age 64 years, body mass index [BMI] 28.5 kg/m²), 72.9% (n=102) were at intermediate-to-high risk for OSA, yet only 19.8% (n=26) had ever discussed the condition with their PCP. Higher BMI was independently associated with elevated OSA screen-positivity, while age showed a non-significant trend; smoking, alcohol use, and ethnicity were not predictive. Conclusions: These findings underscore a missed opportunity for early identification of OSA and support the integration of screening within urology clinics to improve timely diagnosis and management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →